New Results
Seeing beyond the target: Leveraging off-target reads in targeted clinical tumor sequencing to identify prognostic biomarkers
View ORCID ProfileSerghei Mangul, Jaqueline J Brito, Stefan Groha, Noah Zaitlen, Alexander Gusev
doi: https://doi.org/10.1101/2021.05.28.446240
Serghei Mangul
1Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
Jaqueline J Brito
1Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
Stefan Groha
2Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
3Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Noah Zaitlen
4Departments of Neurology and Computational Medicine, University of California Los Angeles, Los Angeles, CA, USA
Alexander Gusev
2Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
3Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Posted May 29, 2021.
Seeing beyond the target: Leveraging off-target reads in targeted clinical tumor sequencing to identify prognostic biomarkers
Serghei Mangul, Jaqueline J Brito, Stefan Groha, Noah Zaitlen, Alexander Gusev
bioRxiv 2021.05.28.446240; doi: https://doi.org/10.1101/2021.05.28.446240
Subject Area
Subject Areas
- Biochemistry (11697)
- Bioengineering (8714)
- Bioinformatics (29118)
- Biophysics (14924)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14138)
- Epidemiology (2067)
- Evolutionary Biology (18260)
- Genetics (12214)
- Genomics (16759)
- Immunology (11838)
- Microbiology (27986)
- Molecular Biology (11545)
- Neuroscience (60780)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10381)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)